Jump to content Jump to main menu Jump to sub menu


5 September 2012 - We are now on Facebook

QED  now goes social. Connect with us on Facebook and learn more about country specific regulations and potential challenges Read more »

21 August 2012 - World Orphan Drug Congress Europe 2012

21 March 2012 - QED establishes subsidiary in India to extend its reach across Asia Pacific region

QED Clinical Services, a customer focused, full service, global clinical research organization (CRO), has announced the creation of a wholly owned subsidiary “QED Clinical Services India Prviate Limited” in Ahmedabad, India, to enhance its global delivery of clinical trials. Read more »

5 September 2012 - QED launches new orphan drug & rare disease division

QED Clinical Services, a global niche CRO operating in more than 40 countries, has announced that it will address the increasing demand of biotech and pharma companies to develop drugs in rare disease areas. Read more »

6 June 2012 - QED feature in BioSpectrum Asia Digital Magazine

An interview with QED’s CEO, Thomas Ogorka, has today been published in the BioSpectrum Asia Digital Magazine.  Read more »

1 March 2012 - QED in the News: The Evolution of CROs

QED has contributed to a recent article published in InPharm’s Research & Development Guide, March to August 2012.  The article entitled “New research alliances and the evolution of CROs” talks about the different types of models and deals which are being struck by Pharma and CROs.  Given QED’s innovative partnering model the company was ideally placed to comment on the changing dynamics in the field. 

The article can be viewed at http://viewer.zmags.com/publication/e1b199bd#/e1b199bd/4